Genome Sequencing of Polydrug-, Multidrug-, and Extensively Drug-Resistant Mycobacterium tuberculosis Strains from South India. by Shanmugam, Sivakumar et al.
Genome Sequencing of Polydrug-, Multidrug-, and Extensively
Drug-Resistant Mycobacterium tuberculosis Strains from South
India
Sivakumar Shanmugam,a Narender Kumar,b Dina Nair,a Mohan Natrajan,a Srikanth Prasad Tripathy,a Sharon J. Peacock,b,d
Soumya Swaminathan,c Uma Devi Ranganathana
aICMR–National Institute for Research in Tuberculosis, Chennai, India
bDepartment of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
cWorld Health Organization, Geneva, Switzerland
dLondon School of Hygiene and Tropical Medicine, London, United Kingdom
ABSTRACT The genomes of 16 clinical Mycobacterium tuberculosis isolates were
subjected to whole-genome sequencing to identify mutations related to resistance
to one or more anti-Mycobacterium drugs. The sequence data will help in under-
standing the genomic characteristics of M. tuberculosis isolates and their resistance
mutations prevalent in South India.
Tuberculosis (TB) is the leading cause of death due to a single infectious agentworldwide. As per a World Health Organization (WHO) report, an estimated 10
million people developed TB in 2017 (1). The emergence of strains of multidrug-
resistant tuberculosis (MDR-TB) that are resistant to the most effective drugs (rifampin
and isoniazid) poses a threat to TB control programs. These constitute 82% of the
558,000 rifampin-resistant cases reported in 2017 worldwide. Among the MDR-TB cases,
8.5% are identiﬁed as extensively drug-resistant TB (XDR-TB) and have additional
resistance to one of the ﬂuoroquinolones and aminoglycosides. India alone contributed
to 2,650 notiﬁed cases of XDR-TB in 2017 (1, 2). Early and accurate diagnosis of MDR and
XDR-TB followed by appropriate treatment is of critical importance if the number of
new cases is to be reduced worldwide. Here, we describe the use of whole-genome
sequencing (WGS) technology to deﬁne the genetic mutations in isolates from a part
of the world that lacks such data and which could contribute to the genetic prediction
of a tailored treatment regimen for TB patients in the future.
We report the whole-genome sequence of 16 Mycobacterium tuberculosis isolates
from patients in Chennai, India. These have a range of drug resistance patterns that
categorize them as MDR, polydrug-resistant (PDR), or XDR. In order to obtain the
mycobacterial DNA for WGS, M. tuberculosis strains were isolated from sputum samples
of pulmonary tuberculosis patients treated at NIRT, Chennai and grown on Lowenstein-
Jensen (LJ) medium, and colonies were scraped from the 3 growth on the medium
into Tris-ethylenediaminetetraacetic acid (TE) buffer (3–5) followed by genomic DNA
extraction with a cetyltrimethylammonium bromide-sodium chloride (CTAB–NaCl) ex-
traction method (6). Drug susceptibility of the M. tuberculosis isolates was tested with
an automated MGIT 960 instrument as per the manufacturer’s protocol (7, 8). DNA
purity and concentration were determined with Nanodrop (9) and Qubit 3.0 ﬂuorom-
eters, respectively (10). Library preparation was performed with the NEXTFLEX DNA
library kit as deﬁned by the manufacturer’s protocol (11). Brieﬂy, genomic DNA was
sheared to generate fragments of approximately 200 to 600 bp. The fragment size
distribution was checked using an Agilent Bioanalyzer (Agilent Technologies) according
to the manufacturer’s instructions (12). These adapter ligated fragments were subjected
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to 10 rounds of PCR with primers provided in the NEXTFLEX DNA sequencing kit. The
libraries were quantiﬁed using quantitative PCR (qPCR, KAPA library quantiﬁcation kit,
Kappabiosystems) normalized to 1 nM and denatured with 0.1 N NaOH before
sequencing with MiSeq v2 cluster chemistry (Illumina). Raw sequence reads were
ﬁltered with Trimmomatic v0.36 (13) (quality 20) and assembled with SPAdes
v3.11.0 (14) with default parameters, and the contigs larger than 500 bp were
ﬁltered for further analysis. The ﬁltered reads were also aligned to H37Rv (GenBank
accession number NC_000962) using bwa v0.7.12 (15). The alignment obtained was
processed for correction of alignments at indels by the local realignment with a
combination of Picard v2.2.4 (http://broadinstitute.github.io/picard/) and GATK v3.5
(16). The variants were identiﬁed with SAMtools v1.3.1 (17) and were ﬁltered based
on the following parameters: base quality greater than 50, depth greater than 20,
mapping quality greater than 30, and alternate allele proportion greater than 75%.
The variants were further annotated using a custom Python script (https://github
.com/kumarnaren/mtb_vcf_annotator).
Table 1 lists the characteristics of the 16 genomes that were sequenced. The
complete length of the assembled genomes ranged from 4,220,229 to 438,963 bp, with
coverage depth ranging from 52 to 198. Examination of the genetic variants
revealed the presence of the well-known mutations S315T in katG and S450L in rpoB
(18, 19) to be the predominant mutations in isoniazid- and rifampin-resistant isolates,
respectively. Isolates were assigned to lineages 1 to 4 based on the presence or absence
of phylogenetic single nucleotide polymorphisms (SNPs) reported by Coll et al. (18).
Lineage 1 was dominant in our collection of 16 isolates, which is consistent with our
previous reports (3, 5) based on spoligotyping and WGS of drug-susceptible clinical
isolates of M. tuberculosis.
The sequenced genomes of these isolates will contribute toward an understanding
of the genomic characteristics of strains of M. tuberculosis that are prevalent in India,
including the genetic mutations that cause resistance. In particular, these data add to
knowledge about isolates from South India and provide a resource for future studies of
M. tuberculosis in the region.
Data availability. The whole-genome sequence reads of the Mycobacterium
tuberculosis isolates reported here are deposited in the Sequence Read Archive
(SRA) under accession number PRJNA492975. This whole-genome shotgun project
(assembly) has been deposited in GenBank under the accession numbers SDOF00000000
to SDOU00000000. The versions described in this paper are accession numbers
SDOF01000000 to SDOU01000000.
TABLE 1 Summary of sequence details, drug resistance category, and lineage prediction for M. tuberculosis isolates
NCBI
identiﬁcation
no.a
Assembly
accession no.
Coverage
depth ()
Read
length
(bp)
GC
content
(%)
N50
value
(bp)
No. of
contigs
>500
Genome
size (bp)
Reference
coverage
(H37Rv) (%)
No. of
tRNAs
No. of
rRNAs
No. of
coding DNA
sequences Lineage
NIRTX002_PDR SDOU00000000 74 151 65.58 90,381 103 4,220,229 99.3 44 0 3,997 1
NIRTX003_XDR SDOT00000000 131 151 65.58 98,656 107 4,375,554 99.2 45 3 4,139 3
NIRTX004_XDR SDOS00000000 79 100 65.35 57,187 136 4,233,503 96.3 45 2 4,112 4
NIRTX005_XDR SDOR00000000 80 150 65.37 60,784 140 4,262,450 96.8 45 4 4,163 4
NIRTX006_XDR SDOQ00000000 75 76 65.59 98,740 114 4,350,302 98.6 45 3 4,119 2
NIRTX007_PDR SDOP00000000 85 76 65.58 85,411 133 4,389,631 99.5 45 3 4,145 1
NIRTX008_XDR SDOO00000000 52 76 65.67 114,871 89 4,300,325 97.5 45 1 4,068 4
NIRTX009_XDR SDON00000000 91 76 65.59 108,252 91 4,379,992 99.3 45 3 4,103 1
NIRTX010_PDR SDOM00000000 69 76 65.61 72,683 127 4,329,145 98.1 45 3 4,118 2
NIRTX011_XDR SDOL00000000 60 76 65.59 115,334 96 4,384,136 99.4 45 3 4,113 1
NIRTX015_MDR SDOK00000000 198 76 65.59 105,690 109 4,366,330 99.0 45 3 4,113 1
NIRTX016_MDR SDOJ00000000 71 76 65.59 104,750 99 4,378,706 99.3 45 3 4,123 1
NIRTX019_MDR SDOI00000000 53 76 65.56 97,386 98 4,370,427 99.1 45 3 4,113 1
NIRTX022_MDR SDOH00000000 174 151 65.61 94,182 101 4,362,069 98.9 45 3 4,136 4
NIRTX024_MDR SDOG00000000 68 151 65.56 105,728 92 4,383,766 99.4 45 3 4,152 1
NIRTX025_MDR SDOF00000000 92 151 65.54 25,670 323 4,380,819 99.9 49 8 4,295 1
aMDR, multidrug-resistant TB; XDR, extensively drug-resistant TB; PDR, polydrug-resistant TB.
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